Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01679457
Other study ID # 2012-P-001010/1; McLean
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2012
Est. completion date August 2019

Study information

Verified date August 2022
Source Mclean Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study is to learn how to improve treatment for clients who are working hard in treatment at the McLean Hospital Obsessive Compulsive Disorder Institute (OCDI), but who are not making the progress that would typically be expected. Therefore, the investigators will be comparing the performance of such clients in a treatment as usual (TAU)-Exposure and Response Prevention (ERP) session with their performance in an Acceptance and Commitment Therapy (ACT)-focused ERP session that follows an ACT booster session. The investigators hypothesize that clients will perform significantly better in the ACT-focused ERP session than they will in the TAU-ERP session. More specifically, the investigators hypothesize that clients and an independent rater will report that in the ACT-focused ERP session, clients performed significantly fewer rituals and/or avoidance behaviors, experienced comparable levels of distress, exerted significantly more effort, had significantly less difficulty getting started with the ERP, were significantly less influenced by their uncomfortable thoughts/feelings, were significantly more willing to experience discomfort, were significantly more focused on working towards what is important to the client. The investigators also hypothesize that an independent rater will rate clients as significantly more compliant with the ACT-focused ERP session than with the TAU-ERP session. The investigators also hypothesize that clients will rate the ACT-focused ERP session as significantly more preferable and acceptable than the TAU-ERP session, and that they will report being significantly more willing to do the ACT-focused ERP session again.


Recruitment information / eligibility

Status Completed
Enrollment 29
Est. completion date August 2019
Est. primary completion date August 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Participants will be adults at least 18 years of age currently enrolled in the residential or day treatment program at the OCDI.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
ACT-Focused ERP

TAU-ERP


Locations

Country Name City State
United States Obsessive Compulsive Disorder Institute at McLean Hospital Belmont Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Mclean Hospital Utah State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Client Post-ERP Session Questions (Day 1). Client Post-ERP Session Questions (Day 1) will be administered immediately after the "Day 1" TAU-ERP session.
Primary Client Post-ERP Session Questions (Day 2). Client Post-ERP Session Questions (Day 2) will be administered immediately after the "Day 2" ACT-focused ERP session.
See also
  Status Clinical Trial Phase
Completed NCT04575805 - Internet-delivered CBM-C for OC-symptoms N/A
Recruiting NCT03677947 - Inference-Based Cognitive Therapy Versus Exposure and Response Prevention for Obsessive-Compulsive Disorder N/A
Recruiting NCT05166707 - An ERP-based Mobile Intervention as an Adjunctive Treatment for OCD N/A
Completed NCT03284671 - tDCS Stimulation to Treat Patients With Severe and Resistant Obsessive Compulsive Disorder-Pilot Study N/A
Recruiting NCT03799419 - Cognitive Bias Modification for OCD N/A